Jim Simons Anixa Biosciences Inc Transaction History
Renaissance Technologies LLC
- $70.6 Billion
- Q2 2025
A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Anixa Biosciences Inc stock. As of the latest transaction made, Renaissance Technologies LLC holds 27,673 shares of ANIX stock, worth $122,037. This represents 0.0% of its overall portfolio holdings.
Number of Shares
27,673
Previous 21,473
28.87%
Holding current value
$122,037
Previous $61,000
49.18%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding ANIX
# of Institutions
71Shares Held
5.33MCall Options Held
14.1KPut Options Held
12.1K-
Vanguard Group Inc Valley Forge, PA1.39MShares$6.14 Million0.0% of portfolio
-
Laird Norton Trust Company, LLC617KShares$2.72 Million0.28% of portfolio
-
D.A. Davidson & Co.614KShares$2.71 Million0.01% of portfolio
-
Ubs Group Ag505KShares$2.23 Million0.0% of portfolio
-
Mission Wealth Management, LP370KShares$1.63 Million0.03% of portfolio
About Anixa Biosciences Inc
- Ticker ANIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,661,700
- Market Cap $135M
- Description
- Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. The company's therapeutics programs include the development of a chimeric endocrine receptor T-cell technology, a novel form of chimeric antigen receptor T-cell (CAR-T) technology focusing on the...